These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24513131)

  • 21. Investigating the role of relaxin in the regulation of airway fibrosis in animal models of acute and chronic allergic airway disease.
    Mookerjee I; Tang ML; Solly N; Tregear GW; Samuel CS
    Ann N Y Acad Sci; 2005 May; 1041():194-6. PubMed ID: 15956707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β activation and lung fibrosis.
    Tatler AL; Jenkins G
    Proc Am Thorac Soc; 2012 Jul; 9(3):130-6. PubMed ID: 22802287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased arginase activity contributes to airway remodelling in chronic allergic asthma.
    Maarsingh H; Dekkers BG; Zuidhof AB; Bos IS; Menzen MH; Klein T; Flik G; Zaagsma J; Meurs H
    Eur Respir J; 2011 Aug; 38(2):318-28. PubMed ID: 21310883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases.
    Lam M; Royce SG; Samuel CS; Bourke JE
    Pharmacol Ther; 2018 Jul; 187():61-70. PubMed ID: 29447958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into asthmatic airway remodelling through murine models.
    Al Heialy S; McGovern TK; Martin JG
    Respirology; 2011 May; 16(4):589-97. PubMed ID: 21435099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma.
    Hackett TL
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):53-9. PubMed ID: 22217512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.
    Royce SG; Karagiannis TC
    Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):44-8. PubMed ID: 24322009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targets in lung tissue remodelling and fibrosis.
    Liu G; Philp AM; Corte T; Travis MA; Schilter H; Hansbro NG; Burns CJ; Eapen MS; Sohal SS; Burgess JK; Hansbro PM
    Pharmacol Ther; 2021 Sep; 225():107839. PubMed ID: 33774068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Airway remodeling in asthma: clinical and functional correlates].
    Gras D; Bourdin A; Chanez P; Vachier I
    Med Sci (Paris); 2011 Nov; 27(11):959-65. PubMed ID: 22130022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult stem cells for chronic lung diseases.
    Mora AL; Rojas M
    Respirology; 2013 Oct; 18(7):1041-6. PubMed ID: 23648014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair.
    Moodley Y; Ilancheran S; Samuel C; Vaghjiani V; Atienza D; Williams ED; Jenkin G; Wallace E; Trounson A; Manuelpillai U
    Am J Respir Crit Care Med; 2010 Sep; 182(5):643-51. PubMed ID: 20522792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial epithelium as a target for innovative treatments in asthma.
    Gras D; Chanez P; Vachier I; Petit A; Bourdin A
    Pharmacol Ther; 2013 Dec; 140(3):290-305. PubMed ID: 23880290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic tools assessing airway remodelling in asthma.
    Manso L; Reche M; Padial MA; Valbuena T; Pascual C
    Allergol Immunopathol (Madr); 2012; 40(2):108-16. PubMed ID: 22236733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice.
    Royce SG; Dang W; Yuan G; Tran J; El-Osta A; Karagiannis TC; Tang ML
    Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):295-306. PubMed ID: 22684086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of transforming growth factor-β in airway remodeling in asthma.
    Halwani R; Al-Muhsen S; Al-Jahdali H; Hamid Q
    Am J Respir Cell Mol Biol; 2011 Feb; 44(2):127-33. PubMed ID: 20525803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation.
    Magalhães GS; Rodrigues-Machado MG; Motta-Santos D; Silva AR; Caliari MV; Prata LO; Abreu SC; Rocco PR; Barcelos LS; Santos RA; Campagnole-Santos MJ
    Br J Pharmacol; 2015 May; 172(9):2330-42. PubMed ID: 25559763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.
    Ogawa H; Ledford JG; Mukherjee S; Aono Y; Nishioka Y; Lee JJ; Izumi K; Hollingsworth JW
    Respir Res; 2014 Nov; 15(1):143. PubMed ID: 25472740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relaxin plays an important role in the regulation of airway structure and function.
    Samuel CS; Royce SG; Burton MD; Zhao C; Tregear GW; Tang ML
    Endocrinology; 2007 Sep; 148(9):4259-66. PubMed ID: 17584966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte-derived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin.
    Garantziotis S; Brass DM; Savov J; Hollingsworth JW; McElvania-TeKippe E; Berman K; Walker JK; Schwartz DA
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):662-7. PubMed ID: 16809636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.